Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis

Clinical trial NCT02222155 · COMPLETED

Trial details

NCT number: NCT02222155
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

ANCA-associated Vasculitis

Start date: 2015-02-04
Primary completion: 2016-04-24
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.